Nasdaq - Delayed Quote USD

PGIM Jennison Health Sciences A (PHLAX)

41.58 +0.15 (+0.36%)
At close: 8:01 PM EDT

Top 9 Holdings (47.00% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 13.23%
BMY
Bristol-Myers Squibb Company 5.20%
UNH
UnitedHealth Group Incorporated 5.14%
VRTX
Vertex Pharmaceuticals Incorporated 4.69%
AMGN
Amgen Inc. 4.27%
ARGX
argenx SE 3.77%
BSX
Boston Scientific Corporation 3.69%
NVO
Novo Nordisk A/S 3.51%
ISRG
Intuitive Surgical, Inc. 3.50%

Sector Weightings

Overall Portfolio Composition (%)

Cash 5.31%
Stocks 94.68%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average PHLAX Category Average
Price/Earnings 0.02 24.55
Price/Book 0.17 5.28
Price/Sales 0.33 2.06
Price/Cashflow 0.04 17.54
Median Market Cap 57,548.56 34,862.81
3 Year Earnings Growth -3.3 32.48

Bond Holdings

Performance & Risk

YTD Return 14.54%
5y Average Return 14.24%
Rank in Category (ytd) 9
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.65
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family PGIM Investments
Net Assets 1.85B
YTD Return 16.84%
Yield 0.00%
Morningstar Rating
Inception Date Feb 03, 2012

Fund Summary

The fund seeks investments whose prices will increase over time. It normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector.

Related Tickers